Staburo @ PSI Medical Stats Careers Event 2021    Staburo's Managing Director Dr. Hannes Buchner took part in the online panel discussion on 3 March 2021 that was the start of the PSI Medical Stats Careers Event 2021. This event was aimed at students with an...

Three Staburo presentations at the Biometric Colloquium Conference in March 2021 Three presentations by Staburo members have been accepted at the Biometric Colloquium “Scenes from Biostatistics” virtual conference of the German Region of the International Biometric...

BioNTech recognizes employees and partners for their support in developing historic vaccine We thank BioNTech for recognizing our biostatistics support in the development of a vaccine against COVID-19! We were very happy to add our expertise to this meaningful project...

Introduction to R online course  Our course “Introduction to R course” will be a 2-day course from 28 to 29 January 2021! The course, which takes place online, is about providing a solid foundation in R, the popular open source programming language in statistics and...

G-BA approves Staburo supported study on cancer treatment through stem cell transplantation A new study in collaboration with Universitätsklinikum Hamburg-Eppendorf (UKE) and CTC North GmbH & Co. KG has been approved by the German Gemeinsamer Bundesausschuss...

Staburo presented @ workshop from the working group Pharmaceutical Research (APF) On November 27, Staburo Managing Director Dr. Hannes Buchner gave a talk at the 74th workshop of the APF (Arbeitsgruppe Pharmazeutische Forschung) of the Deutsche Region der...

Staburo @ the DIA Global Clinical Trial Disclosure & Data Transparency Conference 2020  Staburo participated in the 2020 Global Clinical Trial Disclosure & Data Transparency Conference hosted by the Drug Information Association (DIA) from the 16 - 18 November,...

Staburo @ working group pharmaceutical research (APF) workshop  Staburo Managing Director Dr. Hannes Buchner will talk about “Estimands update: Summary of world-wide authority interaction” together with Kaspar Rufibach from Roche at the 74th Arbeitsgruppe...